Two Sigma Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,956
Closed -$1.32M 723
2025
Q4
$1.32M Buy
+12,956
New +$1.04M ﹤0.01% 1349
2023
Q2
Sell
-92,866
Closed -$6.3M 2463
2023
Q1
$6.3M Buy
+92,866
New +$5.97M 0.02% 718
2022
Q3
Sell
-19,700
Closed -$776K 2604
2022
Q2
$776K Buy
19,700
+6,600
+50% +$353K ﹤0.01% 1719
2022
Q1
$916K Buy
+13,100
New +$958K ﹤0.01% 1682
2021
Q2
Sell
-5,981
Closed -$788K 2519
2021
Q1
$788K Buy
+5,981
New +$819K ﹤0.01% 1788
2019
Q4
Sell
-81,504
Closed -$7.37M 2385
2019
Q3
$7.37M Sell
81,504
-146,199
-64% -$16.7M 0.02% 637
2019
Q2
$26.9M Buy
227,703
+8,798
+4% +$886K 0.07% 327
2019
Q1
$19M Buy
+218,905
New +$18.6M 0.05% 433
2018
Q3
Sell
-20,054
Closed -$1.2M 2280
2018
Q2
$1.2M Buy
+20,054
New +$1.08M ﹤0.01% 1535
2018
Q1
Sell
-54,182
Closed -$2.85M 2332
2017
Q4
$2.85M Buy
+54,182
New +$2.89M 0.01% 1079
2014
Q3
Sell
-15,203
Closed -$259K 2430
2014
Q2
$259K Buy
+15,203
New +$209K ﹤0.01% 2096

Other funds holding EXAS

Two Sigma Advisers's EXAS Position: Q1 2026 in Review

Two Sigma Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12,956 shares — an estimated $1.32M sold.

Two Sigma Advisers first reported a position in EXAS in Q2 2014 and held it in 11 quarters. The position peaked at $26.9M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Two Sigma Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 12,956 Exact Sciences shares in Q1 2026, an estimated $1.32M.
  • Two Sigma Advisers first reported a position in Exact Sciences in Q2 2014 and held it in 11 quarters.
  • Two Sigma Advisers's Exact Sciences position peaked at $26.9M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.